Search GRDN
Guardian Pharmacy Services, Inc.
NYSE · CIK 1802255
Last close42.38
Daily change+1.54 (3.77%)
10 Years gain+164.88%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
GRDN · STANDARD
SIC 5912 · Retail-Drug Stores and Proprietary Stores · Fiscal year end 1231
Fundamental
71.3Momentum
96.4Acceleration
96.4Confidence
60.0Annual Revenue2
Quarterly Revenue10
Annual CFO2
Balance SheetAvailable
RankingLimited
Score Breakdown
Growth12.5 / 25
Quality20.3 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 1.4411 percentage points.
Operating leverageOperating margin improved by 9.2805 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM9.97%OK
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Margin21.22%OK
Operating Margin4.77%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC28.43%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.45B | $292.72M | $72.70M | $100.26M | $86.84M | 20.21% | 5.02% | 5.99% | 32.58% | n/a |
| 2025 FY Dec 31, 2024 | $1.23B | $244.37M | -$62.92M | $57.96M | $43.25M | 19.89% | -5.12% | 3.52% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.41B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-338074, 0001193125-25-274298 |
| Revenue Growth TTM | 9.97% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-338074, 0001193125-25-274298 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-102172 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-102172 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-102172 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-338074, 0001193125-25-274298 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 21.22% | Gross Profit / Revenue | OK | 0001193125-26-338074, 0001193125-25-274298 |
| Operating Margin | 4.77% | Operating Income / Revenue | OK | 0001193125-26-338074, 0001193125-25-274298 |
| ROIC | 28.43% | NOPAT / Average Invested Capital | OK | 0001193125-26-338074, 0001193125-25-274298 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-338074 |
| Current Ratio | 1.65x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001193125-26-102172 |